Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular Carcinoma
NCT ID: NCT01641276
Last Updated: 2015-09-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2012-04-30
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exploratory Study to Determine Tissue Alterations of Advanced Hepatocellular Carcinoma Induced by Electromagnetic Waves of Low Energy Amplitude Modulated to Specific Frequencies During Imaging Study by MRI
NCT02692365
Electromagnetic Tracking and Optical Imaging With ICG for Hepatic Biopsies
NCT04258566
By Developing a Radiomics Model to Predict the Prognosis of Patients With Hepatocellular Carcinoma After Microwave Ablation
NCT03880721
Dual and Single Switching Monopolar RFA Using Separable Clustered Electrode for Treatment of HCC
NCT03699657
Central Obesity and Hepatocellular Carcinoma
NCT03082378
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
hepatitis
hepatitis B carriers patients
Low intensity amplitude-moduled electromagnetic fields
Patients in each arm will be exposed to 30 min of amplitude-moduled low intensity electromagnetic fields only one time.
hepatocellular carcinoma patients
hepatites B carriers patients with associated hepatocellular carcinoma
Low intensity amplitude-moduled electromagnetic fields
Patients in each arm will be exposed to 30 min of amplitude-moduled low intensity electromagnetic fields only one time.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low intensity amplitude-moduled electromagnetic fields
Patients in each arm will be exposed to 30 min of amplitude-moduled low intensity electromagnetic fields only one time.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* hepatitis B carriers patients with hepatocellular cancer patients
Exclusion Criteria
* other hepatitis types
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Sirio-Libanes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Frederico Perego Costa
Attending physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frederico P Costa, MD
Role: PRINCIPAL_INVESTIGATOR
Hospital Sirio-Libanes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Sírio Libanês
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Results of a phase II study on patients with hepatocellular carcinoma
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
02621512.3.0000.5461
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.